Effects of 8-oxoberberine on sodium current in rat ventricular and human atrial myocytes

Canadian Journal of Cardiology

Volumn 13, Issue 11, 1997, Pages 1103-1110

  Chi, Jo Feng ^b   Chu, Shu Hsun ^b   Lee, Chih Shone ^b   Su, Ming Jai ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NONE

Author keywords

8 Oxoberberine; Human atrial myocyte; Rat ventricular myocyte; Sodium channel blocking activity

Indexed keywords

8 OXOBERBERINE; BERBERINE DERIVATIVE; JKL 1073A; QUINIDINE; SODIUM ION; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIARRHYTHMIC ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INOTROPISM; MEMBRANE BINDING; MUSCLE ACTION POTENTIAL; NONHUMAN; RAT; SODIUM CURRENT; STEADY STATE; VOLTAGE CLAMP;

ANIMALS; BERBERINE; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; HEART ATRIA; HEART VENTRICLES; HUMANS; MYOCARDIUM; RATS; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS;

EID: 0031467409     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Singh BN, Vaughan Williams EM. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol 1970;39:657-67.
2. Strauss HC, Bigger JT, Hoffman BF. Electrophysiological and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue. Circ Res 1970;26:661-78.
3. Dangman KH, Miura DS. Effects of therapeutic concentrations of procainamide on transmembrane action potentials of normal and infarct zone Purkinje fibers and ventricular muscle cells. J Cardiovasc Pharmacol 1989;13:846-52.
4. Refsum H, Amlie JP, Platou ES, Owren T, Landmark K. Electrophysiological effects of melperone in the dog heart in situ - a new antiarrhythmic drug. Cardiovasc Res 1981;15:131-6.
5. Roden DM, Bennett PB, Snyders DJ, Balser JR, Hondeghem LM. Quinidine delays Iκ activation in guinea pig ventricular myocytes. Circ Res 1988;62:1055-8.
6. Follmer CH, Aomine M, Yeh JC, Singer DH. Amiodarone-induced block of sodium current in isolated cardiac cells. J Pharmacol Exp Ther 1987;243:187-94.
7. Mason JW, Hondeghem LM, Katzung B. Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res 1984;55:278-85.
8. Polster P, Broeckhuysen J. The adrenergic antagonism of amiodarone. Biochem Pharmacol 1976;25:133-40.
9. Su MJ, Lin SO, Wang CH, Tseng TZ, Tseng CD. Comparison of the electrophysiological effect of amiodarone, lidocaine and quinidine on rat ventricular cells. Proc Natl Sci Counc Repub China 1990;14:105-13.
10. Nishimura M, Follmer CH, Singer DH. Amiodarone blocks calcium current in single guinea pig ventricular myocytes. J Pharmacol Exp Ther 1989;251:650-9.
11. Lathrop DA, Nánasi PP, Schwartz A, Varro A. Ionic basis for OPC-8212-induced increase in action potential duration in isolated rabbit, guinea pig and human ventricular myocytes. Eur J Pharmacol 1993,240:127-37.
12. Nakaya H, Tohse Y, Takeda Y, Kanno M. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes. Br J Pharmacol 1993;109:157-63.
13. Hondeghem LM, Synder DJ. Class III antiarrhythmic agents have a lot of potential but a long way to go. Circulation 1990;81:686-90
14. Hondeghem LM, Katzung BG. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta 1977;472:377-98.
15. Mitra R, Morad M. A reliable method for dissociation of myocytes from heart and stomach of vertebrates. Am J Physiol 1985;18:H1056-60.
16. Su MJ, Chang YM, Chi JF, Lee SS. Thaliporphine, a positive inotropic agent with negative chronotropic action. Eur J Pharmacol 1994;254:141-50.
17. Chi JF, Chu SH, Lee CS, Chou NK, Su MJ. Mechanical and electrophysiological effect of 8-oxoberberine (JKL1073A) on atrial tissue. Br J Pharmacol 1996;118:503-12.
18. Escande D, Coulomb A, Faivre JF, Deroubaix E, Coraboeuf E. Two types of transient outward currents in adult human atrial myocytes. Am J Physiol 1987;252:H142-8.
19. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recordings from cells and cell-free membrane patch. Eur J Pharmacol 1981;341:85-100.
20. Wenckebach KF. Cinchona derivatives in the treatment of heart disorders. JAMA 1923;81:472-4.
21. Levy S, Azoulay S. Stones about the origin of quinquina and quinidine. J Cardiovasc Electrophysiol 1994;5:635-6.
22. Roden DM. Long QT syndrome and torsades de pointes: basic and clinical aspects. In: El-Sherif N, Samet P, eds. Cardiac Pacing and Electrophysiology. Philadelphia: WB Saunders, 1991:265-84.
23. + current in rat ventricle. Br J Pharmacol 1995;115:335-43.
24. Su MJ, Morad M. Effect of quinidine and lidocaine on action potential and membrane currents of frog ventricles. Proc Natl Acad Sci Repub China 1987;11:362-9.
25. Koumi S, Sato R, Kaiori R, Hisatoma I, Nagasawa K, Hagakawa H. Sodium channel states control binding and unbinding behavior of antiarrhythmic drugs in cardiac myocytes from the guinea pig. Cardiovasc Res 1992;26:1199-205.
26. Hille B. Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 1977;69:497-515.
27. Bean BP, Cohen CJ, Tsien RW. Lidocaine block of cardiac sodium channels. J Physiol 1983;81:613-42.